Variant report

Variant	nsv975163
Chromosome Location	chr11:26609968-26620267
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr11:26586123..26588285-chr11:26619056..26621228,2	K562	blood:

Extended variants
information (count: 494 )
Associated
traits (count: 53 )

Variant overlapped rSNPs/rCNVs (count:494 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs76051310	chr11:26609970-26609971	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs552032695	chr11:26610049-26610050	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs12294962	chr11:26610137-26610138	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
4	rs550882543	chr11:26610149-26610150	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs184144623	chr11:26610158-26610159	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs199639785	chr11:26610272-26610273	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs397720766	chr11:26610277-26610278	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs374514202	chr11:26610303-26610304	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs12288077	chr11:26610318-26610319	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
10	rs41468744	chr11:26610375-26610376	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
11	rs145582211	chr11:26610384-26610385	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs534207261	chr11:26610388-26610389	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs555427239	chr11:26610403-26610404	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs369092465	chr11:26610415-26610416	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs573420325	chr11:26610497-26610498	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs534710818	chr11:26610505-26610506	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs544495294	chr11:26610507-26610508	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs421694	chr11:26610518-26610519	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs577844536	chr11:26610525-26610526	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs538820492	chr11:26610529-26610530	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs188498225	chr11:26610546-26610547	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs572506744	chr11:26610696-26610697	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs79995025	chr11:26610737-26610738	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs181017101	chr11:26610782-26610783	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs61878564	chr11:26610848-26610849	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
26	rs184367036	chr11:26610879-26610880	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs562972285	chr11:26610935-26610936	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs544542608	chr11:26610955-26610956	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs11423756	chr11:26610961-26610962	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs562771124	chr11:26610967-26610968	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs397713151	chr11:26610975-26610976	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs116637506	chr11:26610987-26610988	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs189056883	chr11:26611033-26611034	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs560636987	chr11:26611037-26611038	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs294004	chr11:26611038-26611039	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs386751923	chr11:26611045-26611046	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs294003	chr11:26611046-26611047	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs537828124	chr11:26611059-26611060	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs550084340	chr11:26611060-26611061	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs374843135	chr11:26611067-26611068	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs114154651	chr11:26611079-26611080	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs147688958	chr11:26611084-26611085	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs554029645	chr11:26611145-26611146	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs543768089	chr11:26611146-26611147	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs567723180	chr11:26611157-26611158	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs572600400	chr11:26611159-26611160	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs533681858	chr11:26611160-26611161	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs140011860	chr11:26611169-26611170	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs113154937	chr11:26611173-26611174	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs368783523	chr11:26611189-26611190	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:53)

Disease	PMID	Source
Burkitt''s lymphoma	19759907	CNVD
Breast cancer	17603634	CNVD
Medulloblastoma	21979893	CNVD
Thyroid cancer	19087340	CNVD
Melanoma	18172304	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Wilms tumour	21544195	CNVD
Parathyroid adenoma	22454399	CNVD
Chordoma	21602918	CNVD
Breast cancer	21949216	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	19222835	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Beckwith-Wiedemann syndrome	21518781	CNVD
Wilms tumour	21518781	CNVD
Hepatoblastoma	21518781	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Paraganglioma	17535989	CNVD
Pulmonary chondroma	17535989	CNVD
Gastric cancer	17908304	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Multiple myeloma	20724749	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Autism	22495311	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Non-small cell lung cancer	21385341	CNVD
Intellectual disability	22102821	CNVD
Breast cancer	21785460	CNVD
Medulloblastoma	16783165	CNVD
small cell lung cancer	20016488	CNVD
Congenital diaphragmatic hernia	21525063	CNVD
Renal cell carcinoma	18194544	CNVD
Potocki-Shaffer syndrome	19222835	CNVD
WAGR syndrome	19222835	CNVD
Chordoma	18071362	CNVD
Autism	22102821	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Breast cancer	21364760	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Neuroticism	17667963	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:25 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:26600400-26643000	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
2	chr11:26603800-26623200	Weak transcription	Pancreatic Islets	Pancreatic Islet
3	chr11:26604000-26623600	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
4	chr11:26606800-26614600	Weak transcription	Placenta	Placenta
5	chr11:26607600-26635400	Weak transcription	Adipose Nuclei	Adipose
6	chr11:26609200-26613800	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
7	chr11:26610200-26610800	Enhancers	Fetal Lung	lung
8	chr11:26610600-26611200	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
9	chr11:26610800-26619000	Weak transcription	Fetal Lung	lung
10	chr11:26611200-26611600	Enhancers	HepG2	liver
11	chr11:26614600-26615600	Enhancers	Fetal Intestine Small	intestine
12	chr11:26614600-26617000	Enhancers	Placenta	Placenta
13	chr11:26615000-26615600	Enhancers	Fetal Intestine Large	intestine
14	chr11:26615600-26616000	Weak transcription	Fetal Intestine Large	intestine
15	chr11:26615600-26616000	Weak transcription	Fetal Intestine Small	intestine
16	chr11:26616000-26617600	Enhancers	Fetal Intestine Large	intestine
17	chr11:26616000-26617600	Enhancers	Fetal Intestine Small	intestine
18	chr11:26616600-26617600	Enhancers	Primary neutrophils fromperipheralblood	blood
19	chr11:26616800-26617400	Enhancers	iPS-18 Cell Line	embryonic stem cell
20	chr11:26617600-26619400	Active TSS	HepG2	liver
21	chr11:26617600-26621000	Weak transcription	Primary neutrophils fromperipheralblood	blood
22	chr11:26619000-26619600	Enhancers	Fetal Lung	lung
23	chr11:26619400-26619600	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
24	chr11:26619400-26619600	Flanking Active TSS	HepG2	liver
25	chr11:26619600-26620800	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links